Skip to main content

Advertisement

Fig. 1 | Cell & Bioscience

Fig. 1

From: miR-26a inhibits atherosclerosis progression by targeting TRPC3

Fig. 1

Effects of miR-26a on hyperlipidemia in HFD-treated apoE−/− mice. a RT-qPCR analysis of miR-26a expression in apoE−/− mice fed with HFD or normal diet. b The body weight of atherosclerosis mice in control, AG, AG-NC, AN, and AN-NC groups. The serum concentrations of TC (c), TG (d), HDL-C (e), and LDL-C (f) in atherosclerosis mice in control, AG, AG-NC, AN, and AN-NC groups. AG: miR-26a agomir, AG-NC: miR-26a agomir negative control, AN: miR-26a antagomir, AN-NC: miR-26a antagomir negative control, *P < 0.05

Back to article page